CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 32 filers reported holding CARDIOME PHARMA CORP in Q2 2016. The put-call ratio across all filers is 8.80 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,757,260 | $8,299,000 | 4.68% |
| Tamarack Advisers, LP | 1,825,000 | $5,493,000 | 3.43% |
| CLOUGH CAPITAL PARTNERS L P | 2,958,415 | $8,905,000 | 0.56% |
| AlphaOne Investment Services, LLC | 550,712 | $1,653,000 | 0.42% |
| Rock Springs Capital Management LP | 1,200,000 | $3,612,000 | 0.21% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 4,894,948 | $14,734,000 | 0.13% |
| KNOTT DAVID M | 76,300 | $230,000 | 0.11% |
| SABBY MANAGEMENT, LLC | 273,010 | $819,000 | 0.04% |
| PUTNAM INVESTMENTS LLC | 3,438,484 | $10,315,000 | 0.02% |
| ARDSLEY ADVISORY PARTNERS LP | 40,000 | $120,000 | 0.02% |